Utah Medical Products, Inc. $UTMD Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC decreased its stake in Utah Medical Products, Inc. (NASDAQ:UTMD) by 4.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 184,114 shares of the medical instruments supplier’s stock after selling 9,500 shares during the period. Renaissance Technologies LLC owned 5.79% of Utah Medical Products worth $11,413,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UTMD. Invesco Ltd. increased its position in Utah Medical Products by 4.2% in the fourth quarter. Invesco Ltd. now owns 6,020 shares of the medical instruments supplier’s stock worth $337,000 after buying an additional 243 shares during the period. O Shaughnessy Asset Management LLC lifted its stake in Utah Medical Products by 2.3% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 14,903 shares of the medical instruments supplier’s stock valued at $834,000 after buying an additional 337 shares during the last quarter. &PARTNERS boosted its holdings in shares of Utah Medical Products by 11.6% during the fourth quarter. &PARTNERS now owns 3,796 shares of the medical instruments supplier’s stock valued at $212,000 after acquiring an additional 396 shares during the period. Sei Investments Co. boosted its holdings in shares of Utah Medical Products by 11.4% during the first quarter. Sei Investments Co. now owns 4,097 shares of the medical instruments supplier’s stock valued at $254,000 after acquiring an additional 419 shares during the period. Finally, Comerica Bank grew its position in shares of Utah Medical Products by 435.6% during the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 440 shares during the last quarter. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Stock Up 1.4%

Shares of NASDAQ UTMD opened at $70.52 on Friday. The stock has a market cap of $224.25 million, a P/E ratio of 21.50 and a beta of 0.36. The firm’s 50-day simple moving average is $68.46 and its 200 day simple moving average is $65.79. Utah Medical Products, Inc. has a fifty-two week low of $53.66 and a fifty-two week high of $75.75.

Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share (EPS) for the quarter. The firm had revenue of $8.53 million during the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.79%.

Utah Medical Products Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 3rd. Stockholders of record on Wednesday, June 17th were paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Wednesday, June 17th. Utah Medical Products’s dividend payout ratio is currently 37.80%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Utah Medical Products in a report on Friday, May 22nd. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold”.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).